Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials

OBJECTIVES: Here, we present the reported incidence rates of inflammatory bowel disease (IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis (PsA) or ankylosing spondylitis (AS), in a pooled analysis of 21 clinical trials. METHODS: Data from all patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiber, Stefan, Colombel, Jean-Frederic, Feagan, Brian G, Reich, Kristian, Deodhar, Atul A, McInnes, Iain B, Porter, Brian, Das Gupta, Ayan, Pricop, Luminita, Fox, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530077/
https://www.ncbi.nlm.nih.gov/pubmed/30674475
http://dx.doi.org/10.1136/annrheumdis-2018-214273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530077/
https://www.ncbi.nlm.nih.gov/pubmed/30674475
http://dx.doi.org/10.1136/annrheumdis-2018-214273

Ejemplares similares